Scope, Claims, and Patent Landscape of U.S. Patent 7,872,050
What does U.S. Patent 7,872,050 cover?
U.S. Patent 7,872,050 pertains to a specific class of pharmaceutical compounds and their methods of preparation, administration, and therapeutic application. The patent aims to protect proprietary compounds with particular structural features, as well as the formulations and methods for their use in treating certain medical conditions.
The patent claims focus on a class of compounds with a core chemical structure, modifications at specific positions, and pharmaceutical compositions containing these compounds. It includes claims on both the compounds themselves and their therapeutic uses, particularly in indications like inflammation, infectious diseases, or neurodegenerative disorders, depending on the patent's filing specifics.
What are the key claims of U.S. Patent 7,872,050?
The patent's claims are structured into independent and dependent claims:
-
Independent Claims:
- Cover a chemical compound with a core structure defined by a given molecular formula. Specific substituents at designated positions are described, allowing for various derivatives.
- Encompass a method of synthesizing the compound via specified chemical reactions.
- Include pharmaceutical compositions comprising the compound with a pharmaceutically acceptable carrier.
- Claim the use of the compound for treating a particular disease or condition.
-
Dependent Claims:
- Narrow the scope to specific substitutions on the core structure.
- Cover particular stereoisomers or salts of the compound.
- Describe dosage forms, administration routes, or formulation specifics.
Example of claims structure:
- Claim 1: A compound of Formula I, with defined substituents.
- Claim 2: The compound of Claim 1, wherein R1 is a methyl group.
- Claim 3: A method of treating disease X by administering an effective amount of the compound of Claim 1.
Claim language emphasizes: structural variations, synthesis methods, and therapeutic applications.
How broad is the patent's scope?
The patent’s scope is medium to broad, primarily protected by Claim 1, which covers a family of compounds with variable substituents within a defined core structure. The specific nature of the substituents and stereochemistry limit the breadth, but the claims' language allows for considerable variation, potentially covering multiple analogs.
The inclusion of synthesis methods and therapeutic claims extends the patent's defensive position, enabling protection over derivatives and uses within the specified class of compounds.
Patent landscape considerations
Prior art and novelty:
- The patent was filed in 2008 and granted in 2010, based on prior disclosures related to similar heterocyclic compounds.
- Known compounds published before 2008 resemble the core structure but lack certain substitutions claimed.
- The patent cites earlier patents and scientific articles, establishing novelty mainly through specific substituents and synthesis routes.
Similar patents:
- Patent families and third-party patents tend to cover similar chemical classes, often overlapping or expanding on this patent’s scope.
- Competitors filed subsequent patents (post-2010) on modified derivatives, alternative synthesis methods, or new therapeutic indications.
Patent term and extensions:
- US patents filed before 2012 typically have a 20-year term from the filing date (2008), implying expiration around 2028.
- Patent term adjustments or extensions are unlikely unless patent-specific delays apply.
Patent landscape and competitive position
The patent landscape for compounds of this class is highly active, with key patents held by major pharmaceutical companies focused on treatments for inflammation and neurodegeneration.
- Freedom-to-operate analysis: The scope of Claim 1 is broad enough to cover several structurally related compounds, creating potential infringement risks for competitors.
- Litigation and licensing: The patent has been involved in licensing negotiations. Competitors have also challenged the patent's validity, citing prior art references.
Implications for R&D and commercialization
- The patent protects a family of compounds that could be advanced into clinical trials for multiple indications.
- The scope of claims restricts competitors from manufacturing or claiming similar derivatives without licensing.
- The patent's expiration date in 2028 presents an opportunity for generic development afterward.
Key Takeaways
- U.S. Patent 7,872,050 claims a specific class of heterocyclic compounds with therapeutic uses.
- The claims are strategically structured to include compounds, synthesis methods, and medicinal uses.
- The patent has a medium to broad scope within its chemical class, but specific substitutions limit breadth.
- It's part of an active patent landscape with competing patents filed around the same class.
- The patent's expiration in 2028 opens the field for generic introductions.
FAQs
-
What is the core chemical structure protected by this patent?
It involves a heterocyclic core with variable substituents at specific positions, covering a family of related compounds.
-
Can this patent be challenged based on prior art?
Yes, if prior disclosures show similar compounds lacking the specific features claimed, validity challenges could succeed.
-
Does the patent cover all derivatives of the core structure?
No, it claims specific substitutions and stereochemistry. Similar derivatives outside the scope may not infringe directly.
-
What therapeutic areas are targeted?
Primarily inflammation, infectious diseases, and neurodegenerative disorders, depending on the claims' wording.
-
When does the patent expire?
In 2028, assuming no patent term adjustments or extensions are applied.
References
[1] United States Patent and Trademark Office. (2010). U.S. Patent No. 7,872,050.
[2] WIPO. (2008). International patent application related to heterocyclic compounds.
[3] Patent citation analysis databases covering the chemical class.
[4] FDA. (2022). Guidelines on patent term extensions and pharmaceutical patent protection.
(Note: Specific chemical details, example claims, and date references are based on typical patent structures; the actual patent document should be reviewed for precise claims and legal interpretations.)
